
OSR Holdings, Inc. — Investor Relations & Filings
OSR Holdings, Inc. is a healthcare holding company that operates using a hub-and-spoke model to manage a diverse portfolio of subsidiary companies. The company's vision is to accelerate healthcare innovation to improve health and wellness outcomes. It actively evaluates and pursues merger and acquisition opportunities that advance innovative healthcare, either by addressing unmet patient needs or by lowering patient costs and burden. The firm's development activities are focused on a portfolio of therapies and healthcare solutions, including oral immunotherapies for cancer treatment, design-augmented biologics, therapeutic antibodies, and engineered proteins.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-02 | English | |
| PROXY STATEMENT | 2026-05-26 | English | |
| 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | |
| 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | |
| 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47937235 | CURRENT REPORT | 2026-06-02 | English | ||
| 47073266 | PROXY STATEMENT | 2026-05-26 | English | ||
| 45603271 | 10-Q - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-13 | English | ||
| 42032938 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-05-06 | English | ||
| 39151751 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-30 | English | ||
| 35420934 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-22 | English | ||
| 33910620 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-09 | English | ||
| 33256646 | 8-K/A - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-03 | English | ||
| 33191238 | 8-K - OSR Holdings, Inc. (0001840425) (Filer) | 2026-04-02 | English | ||
| 32013135 | 8-K Filing | 2026-01-27 | English | ||
| 13362203 | CURRENT REPORT | 2026-01-14 | English | ||
|
2025
4 filings
| |||||
| 13362205 | CURRENT REPORT | 2025-11-25 | English | ||
| 13362204 | QUARTERLY REPORT | 2025-11-12 | English | ||
| 13362206 | Director's Dealing 2025 | 2025-10-24 | English | ||
| 13362208 | CURRENT REPORT | 2025-10-16 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
OSR Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35169/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35169 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35169 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35169 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35169}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OSR Holdings, Inc. (id: 35169)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.